Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma

Cellular Oncology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2tOOcY0
via IFTTT